학술논문
Disruption of IL-18 signaling via engineered IL-18BP biologics alleviates experimental cholestatic liver disease
Document Type
Article
Author
Source
In Biomedicine & Pharmacotherapy November 2023 167
Subject
Language
ISSN
0753-3322